The professor of neurology and epilepsy specialist at the Cleveland Clinic Lerner College of Medicine discussed the research on seizure freedom scores and their influence on individualized clinical care.
“We’re talking in this context about brain surgery for epilepsy. It is a huge commitment that the patient is making. They deserve an individualized opinion, not a general statement.”
At the 73rd annual meeting of the American Epilepsy Society (AES), December 6-10, 2019, in Baltimore, Maryland, Lara Jehi, MD, professor of neurology, and epilepsy specialist, Cleveland Clinic Lerner College of Medicine, and colleagues unveiled the seizure freedom score (SFS), a method to closely classify pain levels and other measures in patients with epilepsy.
This new tool was focused on helping to expand diagnosis for these patients, instead of diagnosing them based on previously studied large cohorts of patients who dealt with similar seizure burdens. In turn, this allows patients and surgeons to understand more about the severity of the epilepsy and then make a more individualized decision on whether surgery is the right option for them.
In an interview with NeurologyLive, Jehi details the new SFS diagnostic method, and how it can be revolutionary for epilepsy surgery decision making.
For more coverage of AES 2019, click here.